StockNews.com Initiates Coverage on Natural Alternatives International (NASDAQ:NAII)

Stock analysts at StockNews.com began coverage on shares of Natural Alternatives International (NASDAQ:NAII) in a note issued to investors on Wednesday. The brokerage set a “buy” rating on the stock.

Natural Alternatives International Stock Down 2.8 %

Shares of NASDAQ:NAII opened at $4.50 on Wednesday. The business’s 50 day moving average is $4.67 and its 200 day moving average is $5.54. The stock has a market cap of $27.90 million, a P/E ratio of -3.13 and a beta of 0.60. Natural Alternatives International has a 52-week low of $4.11 and a 52-week high of $7.37. The company has a quick ratio of 1.50, a current ratio of 2.56 and a debt-to-equity ratio of 0.11.

Natural Alternatives International (NASDAQ:NAII) last posted its earnings results on Friday, September 27th. The company reported ($0.32) EPS for the quarter. The business had revenue of $29.49 million for the quarter. Natural Alternatives International had a negative net margin of 7.53% and a negative return on equity of 10.23%.

Institutional Trading of Natural Alternatives International

An institutional investor recently raised its position in Natural Alternatives International stock. Geode Capital Management LLC raised its holdings in shares of Natural Alternatives International, Inc. (NASDAQ:NAII) by 6.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 45,062 shares of the company’s stock after purchasing an additional 2,915 shares during the period. Geode Capital Management LLC owned 0.73% of Natural Alternatives International worth $258,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 32.40% of the company’s stock.

Natural Alternatives International Company Profile

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.